Sana Biotechnology, Inc. is a Strong Buy with promising cell therapies for diabetes & B-cell disorders. Click here to find ...
Global Trial to Assess Injectable Biologic Therapy for Pain Relief and Functional Improvement in Patients with Knee Osteoarthritis — CHAPEL HILL, N ...
There is no cure yet for OA of the knee. Short-term measures such as oral pain medications, physical therapy or steroid injections into the knee can provide short-term relief. There are only a handful ...
AfroTech on MSN
Crystal Brown Didn’t Study Biology, But She Co-Founded An AI Drug Discovery Biotech Company That’s Raised Over $3M
Brown stayed with the company and eventually moved up to director of operations. Then the startup went public. With a ...
“Our work is the first to directly test how chromosome structure affects bacterial growth, survival, and ability to cause ...
Vir's Phase 2 trial saw 39% and 46% HBsAg loss in doublet and triplet regimens for patients with low baseline HBsAg. 100% of participants in the triplet regimen with HBsAg loss achieved anti-HBs ...
UNITY Biotechnology, Inc. reported its financial results for the first quarter of 2025, highlighting the 24-week and partial 36-week topline data from its Phase 2b ASPIRE study in diabetic macular ...
Sona Nanotech Inc ( ($TSE:SONA) ) has shared an announcement. Sona Nanotech Inc. has announced an upcoming investor webinar to discuss its early ...
ATHENS, Ga. & SAN JOSE, Calif.--(BUSINESS WIRE)--Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the ...
On Tuesday, Sana Biotechnology Inc (NASDAQ:SANA) released the initial results from a first-in-human study transplanting UP421, an allogeneic primary islet cell therapy engineered with Sana’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback